Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OBGYN week in review: embryo transfer, fentanyl, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, October 30 - Friday, November 3, 2023), and click each link to read and watch anything you may have missed.
1.) Advantages of delaying embryo transfer after pregnancy loss
In a recent study, women with an interpregnancy interval under 3 months, more often had worse pregnancy outcomes compared to those with an interval of 3 to under 6 months or of 6 to 12 months.
Click here for the full article.
2.) Prenatal fentanyl exposure and a novel syndrome
In a recent study, physical abnormalities were seen among children born from pregnancies complicated by fentanyl.
Click here for the full article.
3.) Utility of pelvic ultrasound imaging in diagnosing endometriosis
Findings and significance for gynecologic surgeons.
Click here for the full article.
4.) Artificial intelligence for embryo evaluation
In a recent study, models for embryo evaluation using artificial intelligence had strong accuracy.
5.) Misoprostol alone effective for abortion
In a recent story, a completed abortion was reported in 98.6% of patients taking a misoprostol alone regimen.
Multimodal physical therapy proves effective for women with chronic pelvic pain
January 6th 2025A recent study highlights multimodal physical therapy as the only conservative treatment with proven efficacy in managing chronic pelvic pain, improving pain intensity, sexual health, and psychological function.
Read More
